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Antibiotic exposure and childhood allergic disease 321disturbing the microflora of the gastrointestinal (GI) tract and therefore jeopardizing the
establishment of oral tolerance and regulatory T cell immune responses. The hygiene hypoth-
esis may not be the only explanation for the rapid increase in the prevalence of allergic dis-
eases and asthma. Further epidemiological and experimental studies addressing the issue of
the impact of environmental factors on the development of allergic diseases and the underly-
ing mechanisms may unveil novel strategies for the prevention and treatment of allergic dis-
eases in the future.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
During the past two decades, allergic diseases have rapidly
grown to afflict more than 20% of the population in indus-
trial countries1 and are associated with a large percentage
of allergy-related comorbidity.2,3 However, explanations
for the rapid and dramatic increase in the prevalence of
allergic diseases are still unsatisfying. Hypotheses assume
that the phenomenon may result from the emergence of
unidentified risk factors or the loss of protective factors in
modern lifestyles. Recently, the hygiene hypothesis pro-
vides clues to the answers and inspires the research
exploring the association between the use of antibiotics
and the development of allergic diseases. Numerous studies
have reported on the association between early life expo-
sure to antibiotics and subsequent allergic disease.4e6
However, the results are not completely consistent7e10
with many debates on the bias of the study design. In this
article, we review very recent epidemiological studies and
delineate the possible mechanisms from the perspective of
the hygiene hypothesis on the basis of current evidence
from cellular and animal studies.Hygiene hypothesis
By means of the successful strategies for controlling infec-
tious diseases in modern society, there has been a great
improvement in human health and longevity, and the threats
to human health have changed from infectious diseases to
chronic diseases. Allergic diseases, such as allergic rhinitis,
atopic dermatitis, and allergic asthma, are chronic inflam-
matory disorders resulting from the complex interaction
between the genetic background and the environments. A
marked steady increase in the prevalence of allergic dis-
eases has been noticed worldwide during recent decades,11
causing a great burden on medical resources. It has been
observed that the development of allergic diseases is asso-
ciated with modern lifestyle, and the increase of allergic
diseases is paralleled to the decrease of infectious diseases
during the same period.12 The decrease in infectious dis-
eases attributes to multiple factors including the estab-
lishment of the public health system, the development of
vaccine and vaccination policy, and the use of antibiotics.
All of these factors contribute to amuchmore hygienic living
environment. Although the genetic background of humans
over past decades is nearly identical, the rapid increase in
the prevalence of allergic diseases is most likely associatedwith changes in environmental factors. The hygiene hy-
pothesis, proposed by Strachan in 1989,13 provides a possible
explanation that the lack of microbial exposure as a result of
very hygienic conditions in early life may have an impact on
the balance of the immune system, which finally leads to the
development of allergic diseases. Although it may not be the
sole explanation for the increase in allergic diseases, the
hygiene hypothesis has been supported by numerous
epidemiological and experimental studies.
Epidemiological evidence for the hygiene
hypothesis
The very early epidemiological study by Strachan suggests
an association between the prevalence of hay fever/atopic
dermatitis and the family size, which means that the higher
infection rate of children with more older siblings protects
against the development of allergic diseases.14 In concor-
dance with the family size study, day care attendance in
early life reduces the risk for asthma and wheezing in high-
risk children15 and in children without a maternal history of
asthma.16 Epidemiological studies comparing the preva-
lence in rural and urban areas also provides support for the
hygiene hypothesis. Growing up in the farming environ-
ment, or even prenatal exposure to such a specific envi-
ronment, results in protection against the development of
atopy, wheezing, and asthma,17e19 and the conclusion is
further supported by identifying the responsible genes with
significant interactions with farm exposure for asthma or
atopy in the farming environment.20
Further evidence for the environmental impact on the
development of allergic disorders is from studies comparing
the prevalence of allergic diseases in the population with
an identical genetic background but with different life-
styles. For example, before the reunification of Germany,
the prevalences of asthma, wheezing, and allergic rhinitis
were quite low,21 and a similar condition was also found in
other countries of Eastern Europe.11,22,23 However, the
prevalence of allergic diseases rapidly increased after the
living condition became westernized.24 These epidemio-
logical studies have provided evidence for the imprinting
effect of infection in early life on the prevention of allergic
diseases later in life.
Experimental evidence for the hygiene hypothesis
During pregnancy, the environment of the fetus in the
mother is T helper type 2 (Th2)-predominant to protect
322 C.-H. Kuo et al.the fetus from being rejected. After birth, in very early life,
the immune system retains the Th2-predominant response
in continuation of the environment of the fetus.25 In early
childhood, the immune system is challenged by infections
and gradually deviates to the T helper type 1 (Th1)
response, which helps to restore the balance between Th1
and Th2 responses later in life.26 Because allergy is pro-
posed as a typical Th2-predominant disease,27 it is postu-
lated that the lack of microorganism exposure in early life
prevents the deviation from the Th2 to Th1 response and
results in a persistent status of Th2 predominance. In the
murine asthma model, early administration of microor-
ganisms, including attenuated live bacteria (Bacillus
Calmette Gue´rin, BCG),28 killed bacteria,29 components of
bacteria (such as CpG oligodeoxynucleotides),30 Chla-
mydia,31 virus,32 or even parasite,33 has preventive or
inhibitory effects on the development of allergic diseases
and asthma. The cellular and molecular mechanisms ac-
counting for the phenomenon have been postulated from
the role of innate and adaptive immunity. In addition to the
lack of the Th1 response triggered by infection, the lack of
a regulatory immune response that limits the Th2 response
in preventing an allergic reaction may also be involved.
The induction of regulatory T cells (Tregs), which pro-
duce interleukin (IL)-10 as well as transforming growth
factor (TGF)-b and express the costimulatory molecule
cytotoxic T lymphocyte-associated antigen-4 (CTLA-4),
plays a key role in regulatory immune responses.34,35 There
are two major groups of Tregs, the natural CD4þCD25þ
Tregs (nTregs) and the inducible Tregs (iTregs). Tregs inhibit
both Th1 and Th2 responses and are critical for regulating
allergic reaction and autoimmunity.36,37 The inhibitory ef-
fect can be antigen-specific or antigen-nonspecific,
depending on the types of Tregs.38 The induction of Tregs
is an important one of the mechanisms by which the in-
fections with bacteria39,40 or helminthes41 modulate and
attenuate the allergic responses and asthma.
In addition to T cells, dendritic cells (DCs) are also
important in regulatory immune responses. DCs are pro-
fessional antigen-presenting cells that induce T cell acti-
vation and orchestrate T cell polarization. DCs are
heterogenous in phenotype and character, and the function
of DCs depends on the production of cytokines, the syn-
thesis of intracellular enzymes, and the expression of cos-
timulatory molecules. DCs have been proven to play an
important role in the pathogenesis of allergic diseases.42
DCs respond to common inhaled aeroallergens43 and lead
to the Th2 response by polarizing the expression of cyto-
kines and costimulatory molecules.44 We and others have
demonstrated that the modulatory effect of some potent
anti-asthmatic medications on the function of DCs is an
important mechanism to inhibit allergic inflammations.45,46
The critical role of DCs in the modulatory effects of early
life infection on allergic responses has been proposed in
recent studies.47e49 These studies reveal that DCs can be
educated by types of microorganisms to become mature
and promote the Th1 response that subsequently inhibits
the Th2 response of allergy.
DCs can be induced to have a tolerogenic function. The
tolerogenic DCs can induce tolerance of T cells by produc-
ing IL-10 to induce T cell anergy,50 by expressing Fas ligand
to cause T cell apoptosis,51 and by inducing differentiationof Tregs. There are several mechanisms by which tolero-
genic DCs induce Tregs. Tolerogenic DCs can produce IL-10,
TGF-b or interferon (IFN)-a, either alone or in combination,
to induce Tregs.52 The synthesis of intracellular enzyme
indoleamine 2,3-dioxypgenase (IDO) in tolerogenic DCs
participates in inducing Tregs.53 The expression of cos-
timulatory molecules, such as OX-2 (CD200) or inducible
costimulatory ligand (ICOS-L), in DCs is involved in the
development of Tregs.54
In contrast to T cells, which use the specific T cell re-
ceptors to recognize pathogen, DCs use the pattern
recognition receptors, such as Toll-like receptors (TLR), to
recognize various types of pathogens. The signaling acti-
vated by different types of pattern recognition receptors,
mainly TLRs, may influence the expression of cytokines,
intracellular enzymes, and costimulatory molecules in DCs.
Accordingly, the signaling alters the function and pheno-
type of DCs and subsequently prevents the development of
allergic diseases.55 The modulatory effects of activated
pattern recognition receptors on the function of DCs may
be a basis for cellular and molecular mechanisms by which
microorganism infection can modulate the allergic
response. Studies have reported that DCs from mice
infected with bacteria suppress allergic inflammation by
increasing IFN-g and IL-12 (the Th1-related cytokines) and
decreasing IL-4, IL-5, IL-9, and IL-13 (the Th2-related cy-
tokines),48 or by producing IL-10 to induce Tregs.39 The
expression of TLRs is not limited to innate immune cells but
can be found in epithelial cells, B cells, or T cells. Inter-
estingly, TLR2 is recently reported to regulate the prolif-
eration of Tregs and affect the suppressive activity of
Tregs.56 These proposed mechanisms by which infection
modulate allergic responses via DCs/T cells are summarized
in Fig. 1.
Early life exposure to antibiotics and the
development of allergic diseases and asthma
Although there were regional variations in prescription
rates, the use of antibiotics in early childhood were mark-
edly increased in the late 1980s and early 1990s.57 This
phenomenon coincides with the increase in the prevalence
of allergic diseases during the past decades, creating
speculation on its causal association. Based on the hygiene
hypothesis, it is rational to propose that the increase of
early life exposure to antibiotics reduces the exposure
of microorganisms and subsequently promotes Th2-
predominant allergic immune responses. Therefore,
numerous retrospective or prospective epidemiological
studies have been performed to evaluate the association
between early life exposure to antibiotics and the devel-
opment of allergic diseases and asthma. We have reviewed
and summarized these studies in Table 1, and delineate the
mechanisms by which antibiotics modulate allergic re-
sponses according to current evidence from in vitro and
in vivo experiments (Fig. 2).
Epidemiologic evidence
Initially, the results from most retrospective studies
consistently reveal a positive association between the early
Figure 1. Dendritic cells (DCs) are involved in the modulatory effect of infection on T helper 2 (Th2)-predominant allergic re-
sponses. DCs are activated by microorganisms via pathogen recognition receptors and become mature, and promote the T helper 1
(Th1) response by producing interferon (IFN)-g and interleukin (IL)-12 that subsequently inhibit Th2 responses. DCs also inhibit the
Th2 response by producing IL-10 and interacting with the costimulatory molecule cytotoxic T lymphocyte-associated antigen-4
(CTLA-4) of the T cell to induce T cell anergy, or by expressing Fas ligand (FasL) to induce T cell apoptosis. DCs can differentiate into
tolerogenic DCs, which can produce IL-10 and transforming growth factor (TGF)-b, synthesize intracellular enzyme indoleamine
2,3-dioxypgenase (IDO), and express specific costimulatory molecules such as OX-2 (CD200) or inducible costimulatory ligand (ICOS-
L) to induce regulatory T cells (Tregs), which subsequently inhibit the Th2 response.
Antibiotic exposure and childhood allergic disease 323life exposure to antibiotics and the development of allergic
diseases.4,5,58 However, the conclusion becomes conflicting
in later prospective studies.7,9 The inconsistence reflects
the discrepancy of study design, the methods of analysis,
and the adjustment for confounding factors between these
investigations.
It is criticized that most retrospective studies require
questionnaires that have to be completed by parents, and
the results from these studies can be affected by recall bias
because parents of asthmatic children may have more
medical visits and are more likely to report the early life
use of antibiotics. In addition, the diagnosis of allergic
diseases and asthma in the retrospective studies may not be
ascertained according to just the statement of the parents
but rather from objective medical records. In order to
verify the hypothesis ideally, prospective birth cohort
studies are carried out. In a meta-analysis report by Marra
et al,8 most of the prospective studies cannot yield a pos-
itive association,7,9,59 except for the results from the study
by McKeever et al,10 which enrolled 21,129 subjects and
found a positive association between early life exposure to
antibiotics and the development of asthma. In case-control
studies, the results are also conflicting. Thomas et al60
report a positive association between antibiotics use
within the first years of life and subsequent wheezing aswell as atopy, whereas Mullooly et al61 report a negative
association between the early life use of antibiotics and
atopy. Even in very recent studies within 5 years, the
conclusion is still controversial, regardless of the retro-
spective or prospective design. The largest retrospective
study enrolling 193,412 subjects62 and the largest pro-
spective study enrolling 251,817 subjects63 both reveal a
positive association. However, others reveal a null associ-
ation after adjustment for some confounding factors,
particular early life respiratory infection64,65 and medical
visits.66 The most debated issue on the positive association
between early life exposure to antibiotics and development
of allergic diseases is the protopathic bias, which indicates
that the early symptoms of asthma, such as prolonged
productive cough, may be the reasons for the use of anti-
biotics. In a birth cohort study, the association between
antibiotic use during the first year of life and development
of wheezing and asthma at the age of 4 years is still sig-
nificant even after adjustment for respiratory infections,64
but the significant association fades away when analyzing
the subgroup of the children without allergic signs in the
first year of life. Similarly, in other studies, the association
is weaker in children with asthma diagnosed after the age
of 3 years than in children with asthma diagnosed earlier.9
In a large database study from Canada, the age at which
Table 1 Studies investigating the association between early life exposure to antibiotics and the subsequent development of a ergic diseases in the pediatric population from
2001 to 2011
Author Year Country Study design N Age (y) Conclusion Ref.
Risnes 2011 US Prospective 1401 0e6 Antibiotics use within the first 6 mon s of life is positively associated with
asthma and allergy at 6 years
67
Mai 2010 Sweden Prospective 3306 0e8 Antibiotics within the first year of life is NOT associated with wheezing and
eczema after adjustment for respira ry infection
64
Su 2010 US Prospective 424 0e5 Antibiotics within the first 9 months f life is NOT associated with asthma
after adjustment for number of illne visits
66
Garcia-
Marcos
2010 Spain Retrospective 13,908 6e7 Antibiotics use within the first year o life is positively associated with
eczema
77
Foliaki 2009 Multiple
countries
Retrospective 193,412 6e7 Antibiotics use within the first year o life is positively associated with
asthma, rhinoconjuntivitis, and ecze a
62
Marra 2009 Canada Prospective 251817 0e9 Antibiotics use within the first year o life is positively associated with
asthma
63
Verhulst 2008 Belgium Prospective 154 0e1 Antibiotics use within the first year o life is positively associated with
wheezing, but the effect is probably ue to reverse causation
96
Wickens 2008 New Zealand Prospective 986 0e4 Antibiotics use within the first 3 and 1 months of life is NOT associated with
asthma and atopy after adjustment f r respiratory infection
65
Kusel 2008 Australia Prospective 198 0e5 Antibiotics use within the first year o life is NOT associated with asthma
and atopy after propensity score adj stment
69
Alm 2008 Sweden Prospective 4921 0e1 Antibiotics use in neonatal period is ositively associated with wheezing 97
Mullooly 2007 US Retrospective 1074 6e16 Antibiotics use with the first 2 years f life is NEGATIVELY associated with
atopy
61
Kozyrskyj 2007 Canada Prospective 13,116 0e7 Antibiotics use with the first year of e is positively associated with atopy 68
Thomas 2006 UK Retrospective 74 3e5 Antibiotics use within the first year o life is positively associated with
wheezing and atopy
60
Ahn 2005 Korea Retrospective 26,400 7e12 Antibiotics use within the first year o life is positively associated with
asthma
98
Johnson 2005 US Prospective 448 0e7 Antibiotics use within the first year of ife is positively associated with atopy 99
Celedon 2004 US Prospective 4408 0e5 Antibiotics use within the first year o life is NOT associated with asthma 9
Cohet 2004 New Zealand Retrospective 1584 8e9 Antibiotics use within the first year o life is positively associated with
asthma
6
Celedon 2002 US Prospective 448 0e5 Antibiotics use within the first year o life is NOT associated with asthma
and atopy
7
McKeever 2002 UK Prospective 29,238 0e11 Antibiotics use within the first year o life is positively associated with
asthma, eczema, and hay fever
10
Wjst 2001 Germany Retrospective 1149 5e14 Antibiotics use within the first year o life is positively associated with
asthma, but the effect is probably d to reverse causation
58
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Figure 2. The proposed model for the induction of allergic diseases. Hygienic environments (Westernized lifestyle) and early life
exposure to antibiotics result in the decrease of microbial stimulation and the subsequent reduction of the T helper 1 (Th1)
response. Meanwhile, the use of antibiotics disrupts intestinal microflora, causing polarization towards the T helper 2 (Th2)
response. In addition, the disruption of intestinal microflora by antibiotics suppresses the Treg response, leading to upregulation of
the Th2 response. These processes contribute to the deviation towards the Th2 response and the development of allergic diseases.
Antibiotic exposure and childhood allergic disease 325asthma is diagnosed has no influence on the association.63
Some studies have several strategies to reduce the bias.
For example, in a very recent prospective study,67 the
exposure to antibiotics occurring near the onset of asthma
symptoms is excluded, and only the antibiotics used for
indications other than asthma-like symptoms is included.
The results show a strong association between antibiotics
exposure before 6 months of age and asthma diagnosed
after the age of 3 years, and this strong association is found
particularly in children who did not have lower respiratory
tract infection in their first year of life.
The doseeresponse relationship between early life
exposure to antibiotics and the development of asthma
supports the conclusion of positive association. Three large
prospective studies investigating the connection and the
doseeresponse relationship reveal that the more courses of
antibiotics taken during the first year of life, the more
likely the risk of developing asthma.10,63,68 In most studies
the information about the types of antibiotics are not well
clarified. It is believed that broad-spectrum antibiotics are
more potent in reducing microbial exposure and altering
microflora in the gut than narrow-spectrum antibiotics, and
some studies have verified that the association between
early life exposure to broad-spectrum antibiotics and the
development of allergic diseases is stronger than that be-
tween early life exposure to narrow-spectrum antibiotics
and the development of allergic diseases,10,68 supporting
the hypothesis that the effect of antibiotics on the devel-
opment of allergic diseases is by decreasing the exposure to
microorganisms and by changing the microflora of the gut.
Among the categories of antibiotics, all kinds of antibiotics
are associated with an increased risk of developing asthma
but the use of macrolides in particular has the strongest
association.63The association of early life exposure to antibiotics and
development of allergic diseases and asthma seems more
prominent in children without family history of atopy or
asthma.67,68 Many studies have also addressed the rela-
tionship between early life exposure to antibiotics and the
alternation of immune responses, with methods such as the
measurement of immunoglobulin E levels64,69 and the skin
prick test.4 However, all of these studies do not find a sig-
nificant association. Because antibiotics do not change the
immune response in children with a family history of atopy
or asthma, it is reasonable to explain the null association in
studies that only include children with a family history of
asthma.7,69Mechanism 1dImmunomodulatory effects of
antibiotics
Antibiotics with potential anti-inflammatory effects were
widely discovered during recent decades. The immune re-
sponses induced by infection include the recruitment of
inflammatory cells as well as the production of proin-
flammatory mediators. Some antibiotics, particularly mac-
rolides, are found to exert an anti-inflammatory effect not
only by inducing apoptosis of inflammatory cells but also by
modulating the production of proinflammatory mediators.70
Moreover, macrolides inhibit IL-8 expression by human
bronchial epithelial cells71 and prevent neutrophil infiltra-
tion into the lung tissue.72 The key mediators of the Th1
response, such as TNF-a, IL-6, and IL-1b, can be suppressed
by macrolides and quinolones.73 A clinical study reveals
that early life exposure to macrolides in particular have the
strongest association for the development of allergic dis-
eases.63 Although there is no direct evidence to prove the
326 C.-H. Kuo et al.cause-and-effect relationship, it can be speculated that the
suppression of Th1 mediators by antibiotics may result in
the deviation towards the Th2 response and, accordingly,
promote the development of allergic diseases.
Another possible mechanism by which antibiotics sup-
press the Th1 response is that the use of antibiotics in-
terferes with the natural course of infection. The fever and
infection episodes are found to be inversely related to the
prevalence of atopy and bronchial hyperresponsiveness.74
Infections in the first year of life frequently induce fever
and the synthesis of IFN-g.75 Although IFN-g is the hallmark
of the Th1 response, frequent use of antipyretics and an-
tibiotics may prevent the production of IFN-g and result in
the deviation towards the Th2 response.76,77 Whether the
frequency or the type of the infection can protect the
development of asthma is still inconclusive. The proposed
mechanism is summarized in Fig. 2.Mechanism 2dRole of antibiotics in intestinal
microbiota and immune tolerance
The gastrointestinal (GI) tract is the largest immune organ
and plays a pivotal role in antigen processing and immune
regulation. The perturbation of commensal bacteria of the
GI tract can be induced by environmental factors78 and is a
common side effect of antibiotics. It is reported that anti-
biotic use during infancy disturbs the quantity and quality
of intestinal microflora and thereby prevents postnatal
maturation of the Th1 response, and further results in the
deviation towards the Th2 response.79 Evidence shows that
an anthroposophic lifestyle influences the composition of
the gut flora, which may contribute to the lower prevalence
of atopic disease in children of these families.80 The normal
bacterial microflora in the GI tract generally controls the
colonization and growth of fungus, such as Candida albi-
cans. Noverr and colleagues found that C. albicans and
other fungi can secrete prostaglandin (PGD)-like molecules
de novo or convert exogenous arachidonic acid to PGD.81,82
Because some PGDs, like PGD2 or PGI2, can promote the Th2
response and inhibit the Th1 response,83,84 the increase of
fungi in the gut may upregulate the Th2 response to foreign
antigens. Namely, overgrowth of fungi in the microflora of
the gut caused by antibiotic therapy may promote Th2
polarization and trigger pulmonary allergic responses.85
Although the GI tract serves as a sensor to ingested al-
lergens, the development of oral tolerance has been asso-
ciated with the modulation of the Th2 response.86 Oral
tolerance helps downregulate the antigen-specific Th2
response in the airway by inducing Tregs.87,88 It is postu-
lated that a lack of certain bacteria, inappropriate strain
colonization, and limited bacterial turnover delay the
development of immune tolerance in infancy.89 The
perturbation of the GI microbiota by antibiotics and
the delay in the establishment of oral tolerance may cause
the defect in the Treg response, resulting in the uncon-
trollable Th2 response to antigens. The proposed mecha-
nism is summarized in Fig. 2.
The hygiene hypothesis provides a credible explanation
for the rapid increase in the prevalence of allergic diseases
in industrial countries during recent decades. However, it
may not be the sole reason for the phenomenon, and is stillfacing numerous challenges. For example, some particular
inner city populations with poor hygienic living conditions
unexpectedly have the highest incidence of asthma.90
Therefore, studies addressing the issue of the impact of
environmental factors, such as early life exposure to
antibiotics or the environmental endocrine-disrupting
chemicals,91e93 on the development of allergic diseases
and the underlying mechanisms are important. The infor-
mation may implicate the approaches for treatment or
prevention of allergic diseases. A good example is the way
to manage allergic diseases by avoiding allergen exposure
until the allergen tolerance has been established. Recently,
great interest has been focused on the effects of probiotics
to treat or prevent allergic diseases.94 Although antibiotics
reduce the exogenous infectious stimuli and disturb the
commensal microflora of the intestine, probiotics may offer
a safe alternative microbial stimulation. However, current
clinical trials do not consistently recommend probiotics as a
standard treatment or prevention for the allergic diseases
of children.95 The efforts in exploring the underlying
mechanisms may ultimately lead to new strategies for
treating and preventing allergic diseases in the future.Conflicts of interest
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